突出编辑委员会对放射化学和放射药学发展的选择。

IF 4.4 Q1 CHEMISTRY, INORGANIC & NUCLEAR EJNMMI Radiopharmacy and Chemistry Pub Date : 2023-10-27 DOI:10.1186/s41181-023-00218-y
Jean DaSilva, Clemens Decristoforo, Robert H. Mach, Guy Bormans, Giuseppe Carlucci, Mohammed Al-Qahtani, Adriano Duatti, Antony D. Gee, Wiktor Szymanski, Sietske Rubow, Jeroen Hendrikx, Xing Yang, Hongmei Jia, Junbo Zhang, Peter Caravan, Hua Yang, Jan Rijn Zeevaart, Miguel Avila Rodriquez, Ralph Santos Oliveira, Marcela Zubillaga, Tamer Sakr, Sarah Spreckelmeyer
{"title":"突出编辑委员会对放射化学和放射药学发展的选择。","authors":"Jean DaSilva,&nbsp;Clemens Decristoforo,&nbsp;Robert H. Mach,&nbsp;Guy Bormans,&nbsp;Giuseppe Carlucci,&nbsp;Mohammed Al-Qahtani,&nbsp;Adriano Duatti,&nbsp;Antony D. Gee,&nbsp;Wiktor Szymanski,&nbsp;Sietske Rubow,&nbsp;Jeroen Hendrikx,&nbsp;Xing Yang,&nbsp;Hongmei Jia,&nbsp;Junbo Zhang,&nbsp;Peter Caravan,&nbsp;Hua Yang,&nbsp;Jan Rijn Zeevaart,&nbsp;Miguel Avila Rodriquez,&nbsp;Ralph Santos Oliveira,&nbsp;Marcela Zubillaga,&nbsp;Tamer Sakr,&nbsp;Sarah Spreckelmeyer","doi":"10.1186/s41181-023-00218-y","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.</p><h3>Main body</h3><p>This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.</p><h3>Conclusion</h3><p>Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.</p></div>","PeriodicalId":534,"journal":{"name":"EJNMMI Radiopharmacy and Chemistry","volume":null,"pages":null},"PeriodicalIF":4.4000,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611660/pdf/","citationCount":"0","resultStr":"{\"title\":\"Highlight selection of radiochemistry and radiopharmacy developments by editorial board\",\"authors\":\"Jean DaSilva,&nbsp;Clemens Decristoforo,&nbsp;Robert H. Mach,&nbsp;Guy Bormans,&nbsp;Giuseppe Carlucci,&nbsp;Mohammed Al-Qahtani,&nbsp;Adriano Duatti,&nbsp;Antony D. Gee,&nbsp;Wiktor Szymanski,&nbsp;Sietske Rubow,&nbsp;Jeroen Hendrikx,&nbsp;Xing Yang,&nbsp;Hongmei Jia,&nbsp;Junbo Zhang,&nbsp;Peter Caravan,&nbsp;Hua Yang,&nbsp;Jan Rijn Zeevaart,&nbsp;Miguel Avila Rodriquez,&nbsp;Ralph Santos Oliveira,&nbsp;Marcela Zubillaga,&nbsp;Tamer Sakr,&nbsp;Sarah Spreckelmeyer\",\"doi\":\"10.1186/s41181-023-00218-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.</p><h3>Main body</h3><p>This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.</p><h3>Conclusion</h3><p>Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.</p></div>\",\"PeriodicalId\":534,\"journal\":{\"name\":\"EJNMMI Radiopharmacy and Chemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2023-10-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611660/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Radiopharmacy and Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://link.springer.com/article/10.1186/s41181-023-00218-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, INORGANIC & NUCLEAR\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Radiopharmacy and Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s41181-023-00218-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
引用次数: 0

摘要

背景:EJNMMI放射药学与化学编辑委员会发布了一份半年一次的精彩评论,以向读者介绍放射药学发展领域的最新趋势。正文:本精选集锦对每位合著编辑委员会成员选择的21个不同主题进行了评论,涉及从新型放射化学到新型放射性药物在人体中的首次应用等多个方面。结论:重点介绍了放射化学和放射药学的发展趋势。热门话题涵盖了EJNMMI放射药学和化学的整个范围,从多个方面展示了该研究领域的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Background

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

Main body

This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

Conclusion

Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.20
自引率
8.70%
发文量
30
审稿时长
5 weeks
期刊最新文献
The development of 177Lu-DOTA-CC-PSMA following a unified "Click Chemistry" protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals. In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions. Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer. Process validation and preclinical development of a new PET cerebral blood flow tracer [11C]MMP for initial clinical trials. Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1